Nasdaq · MRNA
Moderna, Inc. (MRNA)
$236.50+$10.20 (+4.51%)as of 4:00 PM ET Thu 15 Oct
Live quote as of 4:00 PM ET Thu 15 Oct · previous close $226.30 · source: Finnhub
Quarterly revenue
$145.0M
+2.1% vs. a year earlier · Quarter ended 30 Jun 2026
YTD +702%1M +62.4%Mkt cap $94.4B52-wk range $22.36–$236.50
What happened
- Moderna closed at $236.50 on Thursday, 15 October, up 4.51%. It is up 702% this year, at its 52-week closing high.
- In pre-market trading it was at $235.82 (-0.29%) at 8:07 AM ET.
- Its latest reported quarter (quarter ended 30 Jun 2026) showed revenue of $145.0M, up 2% from $142.0M, and net income of -$782.0M.
- Its most recent 8-K, filed 30 Sep 2026, reported a director or officer change and published a Regulation FD disclosure.
- Next earnings: Friday, 6 November; consensus EPS -$1.10.
MRNA price chart
$100$200AugSepOct$237
$100$200MayJunJulAugSepOct$237
$100$200NovDecJan '26FebMarAprMayJunJulAugSepOct$237
Key numbers
| Revenue (latest quarter) | $145.0M+2.1% year over year · Quarter ended 30 Jun 2026 |
|---|---|
| Revenue (last 4 quarters) | $2.2B |
| Net income | -$782.0Mup from -$825.0M a year earlier |
| Diluted EPS | -$1.97vs. -$2.13 a year earlier |
| Operating margin | -562.1% |
| Cash & equivalents | $1.7Bat 30 Jun 2026 |
| Market cap | $94.42BNasdaq |
| 52-week closing range | $22.36 – $236.50high on 15 Oct 2026 |
| Latest periodic report | 10-Qfiled 31 Jul 2026 · period 30 Jun 2026 |
| Next earnings | 6 Nov 2026Nasdaq earnings calendar |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances)Health Care |
Revenue by quarter
In the filing
Moderna's latest 10-Q, filed 31 July 2026 for the period ended 30 June 2026, reported revenue of $145.0M, up 2% from $142.0M a year earlier, and 62.7% less than the previous quarter.
Net income was -$782.0M (up from -$825.0M). Diluted EPS was -$1.97, against -$2.13 a year before. Operating margin was -562.1%. Cash and equivalents stood at $1.7B on 30 Jun 2026.
Latest 8-K · 30 Sep 2026
Moderna reported a director or officer change and published a Regulation FD disclosure. Read on SEC.gov
Earnings vs. expectations
Reported EPS Consensus
Recent SEC filings
| Date | Form | What it is |
|---|---|---|
| 30 Sep 2026 | 8-K | Current report: reported a director or officer change and published a Regulation FD disclosure |
| 1 Sep 2026 | 8-K | Current report: signed a material agreement, took on a new debt obligation, sold unregistered shares and disclosed another material event |
| 31 Jul 2026 | 10-Q | Quarterly report |
| 31 Jul 2026 | 8-K | Current report: reported results of operations |
| 8 Jul 2026 | 8-K | Current report: reported a director or officer change and published a Regulation FD disclosure |
| 11 May 2026 | 8-K | Current report: amended its articles or bylaws and reported shareholder vote results |
| 1 May 2026 | 10-Q | Quarterly report |
| 1 May 2026 | 8-K | Current report: reported results of operations |
The daily filings brief
Before the US open: the movers, the SEC filings and the earnings that matter. Free, one short email per US trading day.
We only use your email to send the brief.